55401-53-1

3β-[(1-Methyl-2-phenylethyl)amino]androst-4-en-17β-ol acetate

4-Piperidinecarboxamide,1-(2-benzoxazolyl)-N-[[2,6-bis(1-methylethyl)phenoxy]sulfonyl]-4-(3-methoxyphenyl)-

3-(2-chlorophenyl)-5-(2-methylphenyl)-1,2,4-oxadiazole

4(1H)-Pyrimidinone,2,3-dihydro-5-isocyano-6-methyl-2-(1-naphthalenyl)-

Ethanesulfonic acid, 2-(dimethylamino)-, methyl ester

4-Piperidinamine, 1-[4-(trifluoromethyl)-2-pyrimidinyl]-

4(1H)-Pyrimidinone,5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)-2-(methylthio)-

4-Piperidinamine,N-[4-amino-5-(2,6-difluorobenzoyl)-2-thiazolyl]-1-(cyclobutylcarbonyl)-

4(1H)-Pyridinone,3-[[[2-[bis(2-hydroxyethyl)amino]ethyl]amino]methyl]-1-[(2,6-difluorophenyl)methyl]-5-(3-methoxyphenyl)-2,6-dimethyl-

Benzenesulfonamide,2,4-difluoro-N-[3-[(2R)-2-pyrrolidinylmethyl]-1H-indol-5-yl]-

4-Piperidinecarboxamide, N-hydroxy-

4-Piperidinamine,N-[4-amino-5-(2,6-difluorobenzoyl)-2-thiazolyl]-1-(ethenylsulfonyl)-

4-Piperidinamine, 1-(2-naphthalenylmethyl)-

4(1H)-Pyrimidinone, tetrahydro-3-(2-phenylethyl)-2-thioxo-

4(1H)-Pyridinone,3-[[bis(2-pyridinylmethyl)amino]methyl]-1-[(2,6-difluorophenyl)methyl]-5-(2-fluoro-3-methoxyphenyl)-2,6-dimethyl-

2-Pyridinamine,5-chloro-6-[4-(difluoromethoxy)-2-methoxyphenyl]-3-(1-ethylpropoxy)-N-methyl-

4-Phenoxathiinol, 6-mercapto-

4-Piperidinamine,N-[4-amino-5-(2,6-difluorobenzoyl)-2-thiazolyl]-1-[(2-ethenyl-5-pyrimidinyl)sulfonyl]-

4-Piperidinamine, 1-(3,3-diphenylpropyl)-N-2-propenyl-

4(1H)-Pyrimidinone, 1-(4,5-dihydroxypentyl)-2-ethoxy-5-ethyl-

4-Piperidinecarboxamide,1-[[2-(acetylamino)-4-[2-[4-[(aminoiminomethyl)amino]phenyl]ethyl]-5-thiazolyl]methyl]-, dihydrochloride

Silane, (7-bromo-9,9-dihexyl-9H-fluoren-2-yl)trimethyl-

4(1H)-Pyrimidinone,2-(cyclopentylthio)-6-[1-(2,6-difluorophenyl)ethyl]-5-methyl-

4(1H)-Quinazolinone,2-[2-(4-chlorophenyl)-2-oxoethylidene]-2,3-dihydro-1-phenyl-, (2E)-

4-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3(4H)-one

8-hydroxyheptadeca-4,6-diyn-3-yl Acetate

4(1H)-Pyrimidinone, 2-(butylamino)-6-phenyl-

4-Piperidinamine,N-[4-amino-5-(2,6-difluorobenzoyl)-2-thiazolyl]-1-[(3-methylphenyl)sulfonyl]-

4-Piperidinamine,N-[4-amino-5-(2,6-difluorobenzoyl)-2-thiazolyl]-1-[(2,4,6-trimethylphenyl)sulfonyl]-

4(1H)-Quinazolinone,2-[(1E,3Z)-3-chloro-4-(4-nitrophenyl)-1,3-butadienyl]-

2-Azetidinone, 3,3-dichloro-4-(4-methoxyphenyl)-1-phenyl-

4(1H)-Quinolinone,8-chloro-2,3-dihydro-2,3-dimethyl-1-[(4-methylphenyl)sulfonyl]-

4-Piperidinecarboxamide,1-[[2-[3,6-bis(methylphenylamino)-9H-xanthen-9-yl]phenyl]sulfonyl]-N-[5-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)pentyl]-

4-Piperidinecarboxamide, 4-phenyl-

4-Piperidinamine,N-[4-amino-5-(2,6-difluorobenzoyl)-2-thiazolyl]-1-[(2-chloro-4-fluorophenyl)sulfonyl]-

4-Piperidinamine,N-[4-amino-5-(2,6-difluorobenzoyl)-2-thiazolyl]-1-(4-methoxybenzoyl)-

4(1H)-Quinolinone, octahydro-2-methyl-, (2R)-

55401-53-1 msds

CAS No 55401-53-1 supplier

CASNo 55401-53-1 distributor

CAS # 55401-53-1 manufacturer

CAS Number 55401-53-1 safety

CAS RN 55401-53-1 wholesale

2026-10-11 Find 3β-[(1-Methyl-2-phenylethyl)amino]androst-4-en-17β-ol acetate,CAS No.55401-53-1,Formula: in ChemGloble